The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and treatment patterns of patients with high-risk localized prostate cancer (HR LPC) treated with radical prostatectomy (RP) and perioperative hormonal therapy (HT) in Japan, South Korea, and Taiwan.
 
Shingo Hatakeyama
No Relationships to Disclose
 
Seung Hwan Lee
No Relationships to Disclose
 
Chun-Te Wu
No Relationships to Disclose
 
Wen-Cheng Chen
No Relationships to Disclose
 
Jae Hoon Chung
No Relationships to Disclose
 
Seong Soo Jeon
No Relationships to Disclose
 
Min Ji Lee
No Relationships to Disclose
 
Ji Youl Lee
No Relationships to Disclose
 
Hyong Woo Moon
No Relationships to Disclose
 
Shintaro Narita
Honoraria - Astellas Pharma; AstraZeneca; Chugai Pharma; Intuitive Surgical; Janssen; Kyorin; Kyowa Kirin; Nippon Shinyaku; Ono Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen
 
Hayato Yamamoto
No Relationships to Disclose
 
Carine Saadoun
Employment - JJ Innovative Medicine
Stock and Other Ownership Interests - JJ Innovative Medicine
Honoraria - JJ Innovative Medicine
Travel, Accommodations, Expenses - JJ Innovative Medicine
 
Anildeep Singh
Employment - JJ Innovative Medicine
Travel, Accommodations, Expenses - JJ Innovative Medicine
 
Jianmin Zhuo
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Cindy Thiow Koon Lim
No Relationships to Disclose
 
Tomonori Habuchi
Honoraria - Astellas Pharma; Daiichi Sankyo; Janssen; Takeda
Research Funding - Mochida Pharmaceutical Co. Ltd.; Sysmex